title: Experience with a totally implantable venous device in children.
abstract: Venous access was attained in 15 children by use of a totally implantable central venous catheter and reservoir. Catheters were in place from 28 to 581 days, giving a cumulative experience of 4,094 days. Although they were well accepted by physicians, parents, and the children, they were not without major complications. These included extravasation of a chemotherapeutic agent in one, migration of the catheter tip to an unacceptable location in another, and catheter thrombosis and catheter-related sepsis in two each. The malpositioned catheter, one of the thrombosed catheters, and both infected catheters were removed. Ease of care, freedom from protruding tubing, and compatibility with normal activities are major positive features of the implantable devices that should be considered when deciding on the type of prolonged central venous access for use in children being treated with cancer.
authors.forename: C H
authors.initials: CH
authors.lastname: Pegelow
authors.forename: M
authors.initials: M
authors.lastname: Narvaez
authors.forename: S R
authors.initials: SR
authors.lastname: Toledano
authors.forename: J
authors.initials: J
authors.lastname: Davis
authors.forename: C
authors.initials: C
authors.lastname: Oiticica
authors.forename: D
authors.initials: D
authors.lastname: Buckner
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001800:Blood Specimen Collection / Q000295:instrumentation; D001803:Blood Transfusion / Q000295:instrumentation; D002404:Catheterization / Q000009:adverse effects / Q000295:instrumentation*; D002648:Child; D002675:Child, Preschool; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology; D005548:Foreign-Body Migration; D006801:Humans; D007223:Infant; D007263:Infusions, Parenteral / Q000295:instrumentation*; D007938:Leukemia / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D010289:Parenteral Nutrition, Total / Q000295:instrumentation; D019736:Prostheses and Implants / Q000009:adverse effects; D018805:Sepsis / Q000209:etiology; D013203:Staphylococcal Infections / Q000209:etiology; D013927:Thrombosis / Q000209:etiology
chemical_list: D000970:Antineoplastic Agents